Medical Simulation System Integration and Delivery

The contract obligates the vendor to fully integrate, deliver, and install a subcutaneous injection site simulator system designed to accurately replicate human subcutaneous tissue for use in pharmaceutical research, adhering strictly to FDA technical specifications. The system must be capable of facilitating realistic training and testing environments for drug delivery research, ensuring consistency and accuracy in performance validation. Complete acceptance criteria are tied to compliance with the FDA’s technical requirements, and final approval is contingent upon successful testing and certification under mandated protocol standards. This is a small business set-aside subcontract under NAICS code 334510, exclusively available to qualified small businesses, and issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The solicitation was posted on July 23, 2026, with responses due by July 31, 2026. Performance of the contract is expected to occur at an unspecified location, and the vendor must meet all delivery, installation, and testing deadlines without delay. No point of contact information is provided, and full details must be accessed through the provided SAM.gov link.